Research in Infection & Immunity

The "Triple - I" Impact Factor

III champions infection and immunity research totaling $75 million annually in both open and strategic competitions.

Supported programs:

  • 14 CIHR Strategic Training Programs

  • 7 New Emerging Team programs in

    • anti-microbial resistance

    • asthma

    • diabetes

    • host resistance and response

  • 2 Health Research Programs of Excellence in

    • transplantation

    • vaccines

  • 2 strategic grants in HIV/AIDS

  • 20 meritorious operating and multi-user equipment grants in 2002-2003

  • Needs, Gaps and Opportunities Assessment grant in Safe Food and Water

  • Hepatitis C research grants

  • Controlled trial on influenza vaccination and oculo-respiratory syndrome

Champion for the Canadian Research Coalition for Safe Food and Water

Establishing the CIHR HIV/AIDS Research Advisory Committee

Organizes national agenda-setting meetings

  • Autoimmunity November 2003

  • Meeting the Health Challenge of Prion Diseases April 2003

  • Biological Terrorism: Canadian Research Agenda January 2002

Partner in CIHR cross-institute strategic initiatives

  • Regenerative medicine

  • Clinical research

  • Global health

Supports conferences, workshops and symposia

  • Canadian Society of Allergy and Clinical Immunology Meeting

  • Canadian Infectious Disease Society Meeting

  • UBC Stanier Symposium on Vaccine Preparation and Vaccination

Sponsors student and post-doctoral fellow travel awards

  • Canadian Society for Immunology Annual Meeting

  • Meeting the Health Challenge of Prion Diseases